Please note: For security purposes, all medportal accounts are required to enable two factor authentication. New accounts are required to enable it within the first two weeks of activation or your account will be locked out. Instructions are available in the Help section. If you missed the deadline and are currently locked out please contact support@medportal.ca for assistance.

Welcome tomedportal

Your online curriculum management platform for the Michael G. DeGroote School of Medicine at McMaster University.

Forgot your password?

HRLMP memo RE: AMENDMENT: Change in Methodology, Lamotrigine Testing

Effective September 16, 2025, the currently employed method of high performance liquid chromatogr...

Effective September 16, 2025, the currently employed method of high performance liquid chromatography with ultraviolet detection (HPLC-UV), for testing of Lamotrigine will be replaced with a new ho...

Effective September 16, 2025, the currently employed method of high performance liquid chromatography with ultraviolet detection (HPLC-UV), for testing of Lamotrigine will be replaced with a new homogeneous particle-enhanced turbidimetric immunoassay.

Effective September 16, 2025, the currently employed method of high performance liquid chromatography with ultraviolet detection (HPLC-UV), for testing of Lamotrigine will be replaced with a new homogeneous particle-enhanced turbidimetric immunoassay.

Read More

View all news

To see a full chronological list of updates, simply click here to access

xs sm md lg xl